Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Propanc Biopharma ( (PPCB) ) has provided an update.
On May 7, 2025, Propanc Biopharma issued a Promissory Note worth $90,000 to an accredited investor for a purchase price of $75,000, with plans to use the proceeds for general working capital. Additionally, the company entered into a Maturity Extension Agreement with the same investor to extend the maturity date of a previously issued note to June 15, 2025, maintaining all other terms unchanged.
More about Propanc Biopharma
Propanc Biopharma, Inc. operates in the biopharmaceutical industry, focusing on the development of cancer treatments. The company is engaged in creating new therapies for the treatment of cancerous tumors, with a particular emphasis on targeting and eradicating cancer stem cells.
Average Trading Volume: 1,690
Technical Sentiment Signal: Strong Sell
Current Market Cap: $26.36M
See more insights into PPCB stock on TipRanks’ Stock Analysis page.